[SYRS] YoY Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
05-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -15.73%
YoY- -33.57%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 3,762 3,891 5,697 3,828 558 412 -
PBT -6,396 -40,143 -30,253 -26,027 -19,486 -19,793 -15,737 -13.92%
Tax 0 -3,296 -9,201 984 0 0 0 -
NP -6,396 -40,143 -21,052 -26,027 -19,486 -19,793 -15,737 -13.92%
Tax Rate - - - - - - - -
Total Cost 6,396 43,905 24,943 31,724 23,314 20,351 16,149 -14.29%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 -1,067.07 -541.04 -456.85 -509.04 -3,547.13 -3,819.66 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.16 -1.43 -2.24 -4.14 -4.26 -4.66 -4.68 -43.00%
EPS Diluted -0.16 -1.43 -2.24 -4.14 -4.26 -4.66 -4.68 -43.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.